- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06641011
This Study Aims to Evaluate the Effect of Rinsing Off or Blot-drying Silver Fluoride on the Retention of Subsequently-applied Resin- and Glass Ionomer-based Fissure Sealants in Permanent Molars Affected by Molar-Incisor Hypomineralization.
The Effect of Rinsing Off or Blot-drying Silver Fluoride on the Retention of Subsequently-applied Resin- and Glass Ionomer-based Fissure Sealants in Permanent Molars Affected by Molar-Incisor Hypomineralization.
Study Overview
Status
Intervention / Treatment
- Device: Resin based fissure sealant restoration one week after silver fluoride (AgF) application
- Device: Immediate restoration (resin- based) after blot-drying silver fluoride application
- Device: Immediate restoration (GIC) after rinsing silver fluoride application
- Device: Immediate restoration (GI- based) after blot-drying silver fluoride application
- Device: Immediate restoration (Resin based) after rinsing silver fluoride application
- Device: GI- based fissure sealant restoration one week after silver fluoride (AgF) application
Detailed Description
Teeth will be randomized in a parallel design based on the application of restoration time (immediate or one week later), sealant material type (resin or glass ionomer), and for immediate applications, the condition of silver fluoride before restoration (dried with cotton or rinsed gently). A total of 216 permanent molars will be included in the study.
Randomization of molar teeth into six groups according to the restoration time, dental restorative material type, and conditions:
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elif Ballıkaya, DDS, PhD
- Phone Number: +905336401499
- Email: yildirim.elif89@gmail.com
Study Contact Backup
- Name: Gizem Erbas Unverdi, DDS, PhD
- Email: erbasgizem@gmail.com
Study Locations
-
-
-
Ankara, Turkey, 06100
- Recruiting
- Hacettepe University Faculty of Dentistry, Department of Pediatric Dentistry
-
Contact:
- Gizem Erbas Unverdi, DDS, PhD
- Email: erbasgizem@gmail.com
-
Contact:
- Elif Ballıkaya, DDS, PhD
- Phone Number: 05336401499
- Email: yildirim.elif89@gmail.com
-
Principal Investigator:
- Zafer Cehreli, DDS, PhD
-
Principal Investigator:
- Elif Ballikaya, DDS, PhD
-
Sub-Investigator:
- Gizem Erbas Unverdi, DDS, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients and their parents who consent to participate and have signed the informed consent form.
- Patients with at least one permanent molar diagnosed with molar incisor hypomineralization based on EAPD guidelines.
- Fully erupted teeth with ICDAS I or II lesions that necessitate the application of fissure sealants.
- Teeth displaying demarcated opacities on the occlusal surface and at least one additional surface.
Exclusion Criteria:
- Teeth that have existing restorations or cavities.
- Patients currently receiving orthodontic treatment.
- Patients who are uncooperative during dental procedures.
- Teeth affected by dental fluorosis or enamel defects associated with specific syndromes.
- Children with systemic conditions requiring ongoing medication.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Resin based fissure sealant restoration one week after silver fluoride (AgF) application
Resin-based fissure sealant restoration one week after silver fluoride (AgF) application
|
Resin based fissure sealant restoration one week after silver fluoride (AgF) application
|
|
Active Comparator: Immediate resin based fissure sealant after blot drying silver fluoride (AgF) application
|
Blot-drying silver fluoride with cotton pellet followed by resin-based fissure sealant
Other Names:
|
|
Active Comparator: Immediate GI-based fissure sealant after rinsing silver fluoride application
|
Rinsing silver fluoride off and blot-drying of fissures followed by glass ionomer-based fissure sealant
|
|
Active Comparator: Immediate GI-based fissure sealant after blot-drying of silver fluoride application
|
Blot-drying silver fluoride with cotton pellet followed by glass ionomer-based fissure sealant
|
|
Active Comparator: Immediate resin-based fissure sealant after rinsing of silver fluoride application
|
Rinsing silver fluoride off followed by resin-based fissure sealant
|
|
Active Comparator: GI-based fissure sealant restoration one week after silver fluoride (AgF) application
|
GI- based fissure sealant restoration one week after silver fluoride (AgF) application
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention Rate of Fissure Sealants with regard to the type of sealant and AgF pretreatment applied.
Time Frame: From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
The US Public Health Service criteria (secondary caries, anatomical form, marginal adaptation, marginal discoloration) will be used for clinical evaluation of restorations.
The restorations will be evaluated at baseline and 1., 6., 12., 18., 24.
months.
Intra-oral photos will be taken directly after treatment and at control appointments to evaluate discoloration and seconder caries under magnification.
|
From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Caries
Time Frame: From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
The US Public Health Service criteria (secondary caries, anatomical form, marginal adaptation, marginal discoloration) will be used for clinical evaluation of restorations.
The restorations will be evaluated at baseline and 1., 6., 12., 18., 24.
months
|
From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
|
Marginal Integrity of Sealants
Time Frame: From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
The US Public Health Service criteria (secondary caries, anatomical form, marginal adaptation, marginal discoloration) will be used for clinical evaluation of restorations.
The restorations will be evaluated at baseline and 1., 6., 12., 18., 24.
months
|
From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
|
Tooth Sensitivity
Time Frame: From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
The Schiff Cold Air Sensitivity Scale (SCASS) will be used at 1, 6, 12, 18 and 24 months follow-ups to assess the presence of hypersensitivity in affected teeth by applying an air blast perpendicularly on the occlusal surface of the tooth for 1 second at a distance of 1 cm. The patient's response will be recorded according to the following scores: 0 = subject does not respond to the stimulus;
|
From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
|
Color and esthetic Changes
Time Frame: From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
Discoloration of the restorations will be recorded at 1, 6, 12, 18, and 24 months follow-ups.
|
From enrollment to the end of treatment: 14 months (from July 2023 to October 2024). The first-year outcomes are planned for October 2025, and the second-year outcomes are planned for October 2026.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elif Ballikaya, DDS, PhD, Hacettepe University Faculty of Dentistry
- Principal Investigator: Zafer Cehreli, DDS, PhD, Hacettepe University Faculty of Dentistry
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Congenital Abnormalities
- Stomatognathic Diseases
- Tooth Demineralization
- Tooth Diseases
- Stomatognathic System Abnormalities
- Tooth Abnormalities
- Dental Enamel Hypomineralization
- Developmental Defects of Enamel
- Dental Caries
- Dental Enamel Hypoplasia
- Molar Hypomineralization
- Physiological Effects of Drugs
- Protective Agents
- Cariostatic Agents
- Fluorides
Other Study ID Numbers
- TDH-2024-21181 (Other Grant/Funding Number: Hacettepe University Scientific Research Projects)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Rawda Hesham Abd ElAzizRecruitingCaries,Dental | Caries Class IIEgypt
Clinical Trials on Resin based fissure sealant restoration one week after silver fluoride (AgF) application
-
Cairo UniversityNot yet recruiting